1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, August 2017

Biopharmaceutical Analysis & Statistics, August 2017

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

1-30 of about 800 reports

Purchase Reports From Reputable Market Research Publishers

United States Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • $ 5995
  • Industry report
  • August 2017
  • by GlobalData

United States Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices Summary GlobalData’s new report, "United ...

  • Industries : Pharmaceutical, Drug Delivery
  • Countries : United States, North America

Specialty Enzymes Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025

  • $ 5795
  • Industry report
  • May 2017
  • by Transparency Market Research

Global Specialty Enzymes Market: Scope This report on specialty enzymes market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies ...

  • Industries : Biopharmaceutical
  • Countries : World

Market Access Impact (US) [Growth Hormone Deficiency]

  • $ 5440
  • Industry report
  • June 2017
  • by Firstword Pharma

What stops doctors from prescribing your brand? It may be more than one thing Market barriers affect over 20% of growth hormone prescriptions in the US, and most brands lose market share because of them. ...

  • Industries : Biopharmaceutical

Market Access Impact (EU5) [Growth Hormone Deficiency]

  • $ 5440
  • Industry report
  • June 2017
  • by Firstword Pharma

Market barriers may be costing you share, but perception could be the bigger problem Market barriers affect nearly 25% of growth hormone prescriptions in the EU5 countries. Most brands lose market share ...

  • Industries : Biopharmaceutical

Single-use Technologies for Biopharmaceuticals: Global Markets

  • $ 5501
  • Industry report
  • June 2017
  • by BCC Research

- The global market for single-use technology reached $2.7 billion in 2016. The market should reach over $4.3 billion by 2021, growing at a compound annual growth rate (CAGR) of 10.1% from 2016 to 2021. ...

  • Industries : Biopharmaceutical
  • Countries : World

Biopharmaceutical CMO & CRO Market Analysis By Source, By Service Type, By Product And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • July 2017
  • by Grand View Research

Biopharmaceutical CMO & CRO Market Analysis By Source (Mammalian, Non-mammalian), By Service Type (Contract Manufacturing, Contract Research), By Product, And Segment Forecasts, 2014 - 2025 The global ...

  • Industries : Biopharmaceutical
  • Countries : World

Aptamers Market Analysis By Types (Nucleic Acid & Peptide), By Application (Diagnostics, Therapeutics, Research & Developments, Others), By Region, And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • June 2017
  • by Grand View Research

The global aptamers market is expected to reach USD 8.91 billion by 2025 according to a new report by Grand View Research, Inc. Advancements in aptamer development technologies, increasing R&D, and rising ...

  • Industries : Biopharmaceutical

Erythropoietin (EPO) Drugs Market Analysis By Drug Class (Biologics, Biosimilars), By Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others), By Application, And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • May 2017
  • by Grand View Research

The global erythropoietin (EPO) drugs market is expected to reach USD 17.4 billion by 2025, according to a new report by Grand View Research, Inc. Rising incidence of chronic diseases such as CKD and cance ...

  • Industries : Biopharmaceutical

Global Biosimilars Market

  • $ 4250
  • Industry report
  • July 2017
  • by Mordor Intelligence LLP

The global biosimilar market was estimated to be USD XX million in 2016 and is expected to reach USD XX million by 2021, witnessing a CAGR of XX% during the forecast period. Biosimilar is a biological ...

  • Industries : Biopharmaceutical, Generic Drug, Pharmaceutical, Biotechnology, Therapy
  • Countries : World

Global Biopharmaceuticals Market

  • $ 4250
  • Industry report
  • July 2017
  • by Mordor Intelligence LLP

In the year 2015, the global market for biopharmaceuticals was valued at USD 176.9 billion. It is estimated at USD 192.2 million for the year 2016 and is projected to reach USD 291 billion by the yea ...

  • Industries : Biotechnology, Biopharmaceutical, Therapy
  • Countries : World

Global Nucleic Acid Isolation & Purification Market

  • $ 4250
  • Industry report
  • July 2017
  • by Mordor Intelligence LLP

The Global market for Nucleic Acid Isolation & Purification is poised to reach $XX million by 2021 growing at a CAGR of XX%. Every gene manipulation procedure requires genetic material like DNA and RNA. ...

  • Industries : Biotechnology, Biopharmaceutical
  • Countries : World

Japan Biosimilars – A start of Authorized Biosimilar Era? - Biosimilar/BioPharma CMO opportunities – JP Conglomerates – A definite role to play for Global Market!

  • $ 4000
  • Industry report
  • August 2017
  • by MP Advisors

Major JP Innovator vs. Early entrant Mid size Japanese companies- TA focus approach – A Win Win Game! In this report, we attempt to evaluate key upcoming opportunity for Japan BS market, its competitive ...

  • Industries : Biopharmaceutical, Generic Drug
  • Countries : Japan

Skeletal Disease Drug Development Pipeline Review, 2017

  • $ 3995
  • Company report
  • July 2017
  • by GBI Research

Skeletal Disease Drug Development Pipeline Review, 2017 Summary This report provides an overview of the skeletal disease pipeline landscape. The report provides comprehensive information on the therapeutics ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States

EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2026

  • $ 3995
  • Industry report
  • June 2017
  • by GlobalData

EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2026 Summary GHD is an endocrine disorder characterized by the insufficient production of GH by the pituitary gland (CGF, 2003). The ...

  • Industries : Health Services, Biopharmaceutical
  • Countries : Japan, United States

Single-use Bioprocessing Market by Product, Application, Method and End User - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • $ 3840
  • Industry report
  • June 2017
  • by Allied Market Research

Single-use bioprocessing technology consists of disposable products that assist in manufacturing biopharmaceutical products. This technology has been rapidly adopted by various biopharmaceutical companies ...

  • Industries : Biopharmaceutical
  • Countries : World

Global Nanofiber Materials Market for Biomedical Industry 2017-2021

  • $ 3500
  • Industry report
  • May 2017
  • by Infiniti Research Limited

About Nanofibers Materials Nanomaterials, along with advancements in nanotechnology, have the potential to revolutionize existing industries and create entirely new applications. In the last decade, nanotechnology ...

  • Industries : Biopharmaceutical, Biotechnology, Advanced Material, Nanotechnology, Textile
  • Countries : World

Contract Biomanufacturing Services Global Market - Forecast to 2025

  • $ 3600
  • Industry report
  • August 2017
  • by IQ4I Research & Consultancy Pvt. Ltd

The contract biomanufacturing global market is expected to grow at double digit CAGR to reach $36.6 billion by 2025. Biomanufacturing is a widely used term to describe manufacture of biologic molecules ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : China, United States

Cell Line Development Services Global Market - Forecast to 2025

  • $ 3600
  • Industry report
  • August 2017
  • by IQ4I Research & Consultancy Pvt. Ltd

Cell lines are one the major tools used in research for studying the normal physiology and biochemistry of cells, the effects of drugs and toxic compounds on the cells, drug screening and development and ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : China, United States

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • July 2017
  • by Global Markets Direct

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2017 Summary Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) pipeline Target constitutes close to ...

  • Industries : Therapy
  • Countries : World, United States

Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • July 2017
  • by Global Markets Direct

Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Pipeline Review, H2 2017 Summary Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) ...

  • Industries : Therapy, Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : United States, World

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • July 2017
  • by Global Markets Direct

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H2 2017 Summary Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Integrin beta-3 (?3) o ...

  • Industries : Pathology, Therapy, Healthcare, Health Services
  • Countries : United States

Somatostatin Receptor Type 4 (SSTR4) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Somatostatin Receptor Type 4 (SSTR4) - Pipeline Review, H1 2017 Summary According to the recently published report 'Somatostatin Receptor Type 4 (SSTR4) - Pipeline Review, H1 2017'; Somatostatin Recepto ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World

Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) - Pipeline Review, H1 2017 Summary Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H1 2017 Summary Human Cytomegalovirus Envelope Glycoprotein B (gB) - Human Cytomegalovirus envelope glycoprotein B plays an important ...

  • Industries : Pathology, Therapy
  • Countries : United States

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Pipeline Review, H1 2017 Summary According to the recently published report 'T Cell Surface Glycoprotein CD4 - Pipeline Review, ...

  • Industries : Therapy, Pathology
  • Countries : United States, World

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H1 2017 Summary T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - CD28 is a proteins expressed on T cells. It co-stimulates ...

  • Industries : Therapy, Biological Therapy, Drug Discovery and Development, Pathology
  • Countries : World, United States

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H1 2017 Summary Alpha L-Iduronidase (IDUA or EC 3.2.1.76) pipeline Target constitutes close to 9 molecules. Out of which approximately 7 molecules ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Pharmaceutical, Biotechnology, Biological Therapy
  • Countries : United States, World

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H1 2017 Summary Toll Like Receptor 3 (CD283 or TLR3) pipeline Target constitutes close to 14 molecules. Out of which approximately 10 molecules are ...

  • Industries : Pathology, Cancer
  • Countries : World, United States

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H1 2017 Summary According to the recently published report 'Integrin Beta ...

  • Industries : Therapy, Health Services, Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : World, United States

Pancreatic Cancer - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Pancreatic Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H1 2017, provides an overview ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.